Golden State Wealth Management’s GSK GSK Stock Holding History

Golden State Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.8K	Buy	1,446 +301	+26%	+$15.9K	0.01%	635
2026 Q1	$63.2K	Buy	1,145 +2	+0.2%	+$108	0.01%	629
2025 Q4	$56.1K	Buy	1,143 +1	+0.1%	+$47	0.01%	662
2025 Q3	$49.3K	Buy	1,142 +2	+0.2%	+$78	0.01%	686
2025 Q2	$43.8K	Buy	1,140 +1	+0.1%	+$38	0.01%	677
2025 Q1	$44.1K	Buy	1,139 +2	+0.2%	+$73	0.01%	616
2024 Q4	$38.5K	Buy	+1,137	New	+$40.9K	0.01%	628
2020 Q4	–	Sell	-1,580	Closed	-$74K	–	311
2020 Q3	$74K	Buy	+1,580	New	+$79.2K	0.02%	295
2020 Q2	–	Sell	-4,226	Closed	-$200K	–	484
2020 Q1	$200K	Buy	+4,226	New	+$225K	0.09%	158
2019 Q4	–	Sell	-3,719	Closed	-$198K	–	415
2019 Q3	$198K	Buy	3,719 +1	+0%	+$51	0.07%	206
2019 Q2	$185K	Sell	3,718 -88	-2%	-$4.42K	0.06%	237
2019 Q1	$199K	Buy	+3,806	New	+$190K	0.07%	225

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Golden State Wealth Management's GSK Position: Q2 2026 in Review

Golden State Wealth Management increased its GSK (GSK) stake by 26% in Q2 2026, buying an estimated $15.9K and bringing the position to 1,446 shares worth $75.8K. The position accounts for 0.01% of the portfolio, ranked #635.

Golden State Wealth Management first reported a position in GSK in Q1 2019 and has held it in 12 quarters since. The position peaked at $200K in Q1 2020. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Golden State Wealth Management held 1,446 shares of GSK worth $75.8K as of Q2 2026.
Golden State Wealth Management bought 301 GSK shares in Q2 2026, an estimated $15.9K.
GSK made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #635 holding.
Golden State Wealth Management first reported a position in GSK in Q1 2019 and has held it in 12 quarters since.
Golden State Wealth Management's GSK position peaked at $200K in Q1 2020.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.